Skip to main content
Premium Trial:

Request an Annual Quote

Jay Short, Alisa Judge, Andre Hoekema, Shawn Cain

Jay Short, chairman and CEO of Diversa, will retire from the board of directors of Invitrogen within the next six months, the company said in a recent SEC filing.


Alisa Judge was named vice president of human resources for San Diego-based Claritas. Previously, she was vice president for human resources at Chemtronics. Before that, she was director of global staffing and retention at Invitrogen.


Andre Hoekema joins Galapagos as managing director of Galadeno, Galapagos' services unit. Previously, Hoekema was Invitrogen's managing director for corporate development in Europe and before that, held the same position for Molecular Probes.


Shawn Cain was named vice president for manufacturing operations, effective April 25, for Los Angeles-based Arbios Systems, a medical device company. Cain joins Arbios from Becton Dickinson, where he was responsible for two biologics manufacturing facilities. Cain previously worked with WR Grace & Co.'s research division and its wholly owned subsidiary, Circe Biomedical, where he was involved in development of HepatAssist, the artificial liver currently being developed by Arbios. Arbios said that concurrent with Cain's appointment, it has entered into a multi-year lease with American Integrated Biologics on a biosecure facility in Woodstock, Conn., which will be used to manufacture pig liver cells to be used in an Arbios project.

 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.